Aprea Therapeutics, Inc.
APRE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $23 | $22 | $29 | $53 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $4 |
| Total Curr. Assets | $24 | $23 | $30 | $57 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $24 | $23 | $30 | $57 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1 | $0 | $0 |
| Other Curr. Liab. | $2 | $2 | $2 | $5 |
| Total Curr. Liab. | $3 | $4 | $3 | $7 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $0 |
| Total NC Liab. | $1 | $1 | $1 | $0 |
| Other Liabilities | $0 | -$1 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $5 | $4 | $5 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $1 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$321 | -$308 | -$294 | -$181 |
| AOCI | -$11 | -$11 | -$11 | -$10 |
| Other Equity | $351 | $336 | $330 | $241 |
| Total Equity | $19 | $18 | $26 | $50 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $24 | $23 | $30 | $57 |
| Net Debt | -$23 | -$22 | -$29 | -$53 |